KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Dividends Paid - Common (2016 - 2025)

Pfizer (PFE) has disclosed Dividends Paid - Common for 17 consecutive years, with $2.4 billion as the latest value for Q4 2025.

  • Quarterly Dividends Paid - Common changed N/A to $2.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.8 billion through Dec 2025, changed N/A year-over-year, with the annual reading at $9.8 billion for FY2025, 2.72% up from the prior year.
  • Dividends Paid - Common for Q4 2025 was $2.4 billion at Pfizer, roughly flat from $2.4 billion in the prior quarter.
  • The five-year high for Dividends Paid - Common was $7.1 billion in Q3 2024, with the low at $2.2 billion in Q2 2021.
  • Average Dividends Paid - Common over 5 years is $3.1 billion, with a median of $2.4 billion recorded in 2024.
  • The sharpest move saw Dividends Paid - Common surged 208.21% in 2024, then crashed 65.73% in 2025.
  • Over 5 years, Dividends Paid - Common stood at $6.5 billion in 2021, then increased by 3.03% to $6.7 billion in 2022, then plummeted by 65.64% to $2.3 billion in 2023, then skyrocketed by 208.08% to $7.1 billion in 2024, then plummeted by 65.72% to $2.4 billion in 2025.
  • According to Business Quant data, Dividends Paid - Common over the past three periods came in at $2.4 billion, $2.4 billion, and $2.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.